Atlas Trials

Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma

Clinical trial NCT04594772 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04594772
Sponsor
University of Cincinnati
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreas Cancer
Start date
2021-03-17
Primary completion
2025-06-13
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.